Ticker
SAGECompany Name
SAGE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Asset Turnover | Revenues |
---|---|---|---|
6/30/2025 | $ 422.92M | 0.17 | $ 70.41M |
3/31/2025 | $ 469.67M | 0.1 | $ 47.4M |
12/31/2024 | $ 547.22M | 0.08 | $ 41.24M |
9/30/2024 | $ 622.43M | 0.17 | $ 106.4M |
6/30/2024 | $ 697.11M | 0.14 | $ 97.24M |
3/31/2024 | $ 767.6M | 0.12 | $ 91.06M |
12/31/2023 | $ 882.28M | 0.1 | $ 86.45M |
9/30/2023 | $ 949.66M | 0.01 | $ 11.35M |
6/30/2023 | $ 1.08B | 0.01 | $ 10.37M |
3/31/2023 | $ 1.22B | 0.01 | $ 9.4M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Revenues / Assets
(=) Asset Turnover
Asset Turnover for SAGE THERAPEUTICS INC is calculated as follows: Revenues [ $ 6.97M ] / Assets [ $ 738.63M ]
(=) Asset Turnover [ 0.01 ]
Minimum
Dec 31, 2021
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 4.17K |
---|---|
min | -0.79 |
max | 2.36 |
average | 0.53 |
median | 0.4 |
std | 0.52 |